These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 23715049

  • 1. Impact of late calcineurin inhibitor withdrawal on ambulatory blood pressure and carotid intima media thickness in renal transplant recipients.
    Mourer JS, de Koning EJ, van Zwet EW, Mallat MJ, Rabelink TJ, de Fijter JW.
    Transplantation; 2013 Jul 15; 96(1):49-57. PubMed ID: 23715049
    [Abstract] [Full Text] [Related]

  • 2. Late calcineurin inhibitor withdrawal prevents progressive left ventricular diastolic dysfunction in renal transplant recipients.
    Mourer JS, Ewe SH, Mallat MJ, Ng AC, Rabelink TJ, Bax JJ, Delgado V, de Fijter JW.
    Transplantation; 2012 Oct 15; 94(7):721-8. PubMed ID: 22955227
    [Abstract] [Full Text] [Related]

  • 3. Randomized trial comparing late concentration-controlled calcineurin inhibitor or mycophenolate mofetil withdrawal.
    Mourer JS, Hartigh Jd, van Zwet EW, Mallat MJ, Dubbeld J, de Fijter JW.
    Transplantation; 2012 May 15; 93(9):887-94. PubMed ID: 22538450
    [Abstract] [Full Text] [Related]

  • 4. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 15; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 5. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B, Höcker B.
    Pediatr Transplant; 2006 Sep 15; 10(6):721-9. PubMed ID: 16911497
    [Abstract] [Full Text] [Related]

  • 6. 15-year follow-up of a multicenter, randomized, calcineurin inhibitor withdrawal study in kidney transplantation.
    Roodnat JI, Hilbrands LB, Hené RJ, de Sévaux RG, Smak Gregoor PJ, Kal-van Gestel JA, Konijn C, van Zuilen A, van Gelder T, Hoitsma AJ, Weimar W.
    Transplantation; 2014 Jul 15; 98(1):47-53. PubMed ID: 24521775
    [Abstract] [Full Text] [Related]

  • 7. Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study.
    Karie-Guigues S, Janus N, Saliba F, Dumortier J, Duvoux C, Calmus Y, Lorho R, Deray G, Launay-Vacher V, Pageaux GP.
    Liver Transpl; 2009 Sep 15; 15(9):1083-91. PubMed ID: 19718632
    [Abstract] [Full Text] [Related]

  • 8. Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial.
    Weir MR, Pearson TC, Patel A, Peddi VR, Kalil R, Scandling J, Chan L, Baliga P, Melton L, Mulgaonkar S, Waid T, Schaefer H, Youssef N, Anandagoda L, McCollum D, Lawson S, Gordon R.
    Transplantation; 2017 Jan 15; 101(1):157-165. PubMed ID: 26950714
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the Opticept trial.
    Gaston RS, Kaplan B, Shah T, Cibrik D, Shaw LM, Angelis M, Mulgaonkar S, Meier-Kriesche HU, Patel D, Bloom RD.
    Am J Transplant; 2009 Jul 15; 9(7):1607-19. PubMed ID: 19459794
    [Abstract] [Full Text] [Related]

  • 12. Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study.
    Schlitt HJ, Barkmann A, Böker KH, Schmidt HH, Emmanouilidis N, Rosenau J, Bahr MJ, Tusch G, Manns MP, Nashan B, Klempnauer J.
    Lancet; 2001 Feb 24; 357(9256):587-91. PubMed ID: 11558484
    [Abstract] [Full Text] [Related]

  • 13.  Conversion to mycophenolate mofetil monotherapy in liver recipients: Calcineurin inhibitor levels are key.
    Norero B, Serrano CA, Sanchez-Fueyo A, Duarte I, Torres J, Ocquetau M, Barrera F, Arrese M, Soza A, Benítez C.
    Ann Hepatol; 2001 Feb 24; 16(1):94-106. PubMed ID: 28051798
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of cyclosporine and tacrolimus on mycophenolate pharmacokinetics in patients with impaired kidney function.
    Hohage H, Zeh M, Heck M, Gerhardt UW, Welling U, Suwelack BM.
    Transplant Proc; 2005 May 24; 37(4):1748-50. PubMed ID: 15919453
    [Abstract] [Full Text] [Related]

  • 15. Steroid withdrawal improves blood pressure control and nocturnal dipping in pediatric renal transplant recipients: analysis of a prospective, randomized, controlled trial.
    Höcker B, Weber LT, John U, Drube J, Fehrenbach H, Klaus G, Pohl M, Seeman T, Fichtner A, Wühl E, Tönshoff B.
    Pediatr Nephrol; 2019 Feb 24; 34(2):341-348. PubMed ID: 30178240
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure.
    Groetzner J, Kaczmarek I, Schulz U, Stegemann E, Kaiser K, Wittwer T, Schirmer J, Voss M, Strauch J, Wahlers T, Sohn HY, Wagner F, Tenderich G, Stempfle HU, Mueller-Ehmsen J, Schmid C, Vogeser M, Koch KC, Reichenspurner H, Daebritz S, Meiser B, Reichart B, VENINAHTx-Investigators.
    Transplantation; 2009 Mar 15; 87(5):726-33. PubMed ID: 19295318
    [Abstract] [Full Text] [Related]

  • 18. Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Long-term Follow-up From the Randomized SCHEDULE Study.
    Gustafsson F, Andreassen AK, Andersson B, Eiskjær H, Rådegran G, Gude E, Jansson K, Solbu D, Karason K, Arora S, Dellgren G, Gullestad L, SCHEDULE (Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance) Investigators*.
    Transplantation; 2020 Jan 15; 104(1):154-164. PubMed ID: 30893292
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Can we eliminate both calcineurin inhibitors and steroids?
    Lebranchu Y.
    Transplant Proc; 2010 Nov 15; 42(9 Suppl):S25-8. PubMed ID: 21095446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.